These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23579167)

  • 1. Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis.
    Robinson MK; Caminis J; Brunkow ME
    Drug Discov Today; 2013 Jul; 18(13-14):637-43. PubMed ID: 23579167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting sclerostin as potential treatment of osteoporosis.
    Papapoulos SE
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i119-22. PubMed ID: 21339215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerostin and skeletal health.
    Sharifi M; Ereifej L; Lewiecki EM
    Rev Endocr Metab Disord; 2015 Jun; 16(2):149-56. PubMed ID: 25669441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Newly developed drugs to improve bone strength].
    Hagino H
    Clin Calcium; 2016 Jan; 26(1):99-105. PubMed ID: 26728536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis.
    Yavropoulou MP; Xygonakis C; Lolou M; Karadimou F; Yovos JG
    Hormones (Athens); 2014; 13(4):323-37. PubMed ID: 25555179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerostin: a novel target for intervention in the treatment of osteoporosis.
    Lewiecki EM
    Discov Med; 2011 Oct; 12(65):263-73. PubMed ID: 22031665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function.
    Piters E; Culha C; Moester M; Van Bezooijen R; Adriaensen D; Mueller T; Weidauer S; Jennes K; de Freitas F; Löwik C; Timmermans JP; Van Hul W; Papapoulos S
    Hum Mutat; 2010 Jul; 31(7):E1526-43. PubMed ID: 20583295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel SOST gene mutation in a sclerosteosis patient from Morocco: a case report.
    Belkhribchia MR; Collet C; Laplanche JL; Hassani R
    Eur J Med Genet; 2014 Mar; 57(4):133-7. PubMed ID: 24594238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin: recent advances and clinical implications.
    Honasoge M; Rao AD; Rao SD
    Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):437-46. PubMed ID: 25333305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal antibodies to sclerostin for the treatment of osteoporosis].
    Soen S
    Clin Calcium; 2013 Jun; 23(6):884-9. PubMed ID: 23719502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting WNT signaling in the treatment of osteoporosis.
    Baron R; Gori F
    Curr Opin Pharmacol; 2018 Jun; 40():134-141. PubMed ID: 29753194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone.
    Fijalkowski I; Geets E; Steenackers E; Van Hoof V; Ramos FJ; Mortier G; Fortuna AM; Van Hul W; Boudin E
    J Bone Miner Res; 2016 Apr; 31(4):874-81. PubMed ID: 26751728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update and perspectives of anabolic therapies for osteoporosis].
    Endo I; Matsumoto T
    Clin Calcium; 2012 Mar; 22(3):327-33. PubMed ID: 22370299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of bone quality. Drug developments for restoring bone mass and quality in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2008 Mar; 18(3):374-80. PubMed ID: 18310826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis.
    Fayez A; Aglan M; Esmaiel N; El Zanaty T; Abdel Kader M; El Ruby M
    Biomed Res Int; 2015; 2015():517815. PubMed ID: 25984533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin K inhibitors and antisclerostin antibodies. The next treatments for osteoporosis?
    Chapurlat R
    Joint Bone Spine; 2016 May; 83(3):254-6. PubMed ID: 26919802
    [No Abstract]   [Full Text] [Related]  

  • 17. BMP signaling in development and diseases: a pharmacological perspective.
    Bandyopadhyay A; Yadav PS; Prashar P
    Biochem Pharmacol; 2013 Apr; 85(7):857-64. PubMed ID: 23333766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies for the treatment of osteoporosis.
    Lewiecki EM
    Expert Opin Biol Ther; 2013 Feb; 13(2):183-96. PubMed ID: 23253281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Bone Cell Biology to Novel Therapies of Osteoporosis.
    Hofbauer LC
    Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S14-5. PubMed ID: 26536179
    [No Abstract]   [Full Text] [Related]  

  • 20. A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.
    Balemans W; Cleiren E; Siebers U; Horst J; Van Hul W
    Bone; 2005 Jun; 36(6):943-7. PubMed ID: 15869924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.